ArticleBMC microbiology2026
The dual role of cAMP receptor protein (CRP) in regulating type 3 fimbriae expression in Klebsiella pneumoniae CG43S3 in response to oxygen availability.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIn Asian countries, Klebsiella pneumoniae is the predominant pathogen isolated from liver abscesses in patients with diabetes mellitus (DM). Elevated glucose level in DM patients causes various immune problems and may enhance K. pneumoniae virulence. Oxygen availability is another crucial factor influencing virulence factors expression during bacterial infections. The cyclic adenosine monophosphate (cAMP) receptor protein (CRP) plays a key role in mediating virulence factor expression in response to dynamic glucose levels in K. pneumoniae.
resultsThis study investigated the regulation of CRP in type 3 fimbriae expression of K. pneumoniae CG43S3 in response to oxygen availability. We observed that anaerobically grown bacteria exhibited increased type 3 fimbriae expression. Glucose addition increased type 3 fimbriae expression under aerobic conditions but reduced it under anaerobic conditions. Exogenous cAMP supplementation complemented the biphasic role of glucose in response to oxygen availability. Deletion of cyaA (encoding adenylate cyclase) or cpdA (encoding phosphodiesterase) altered type 3 fimbriae expression, highlighting the role of cAMP signaling in this regulation. Under anaerobic conditions, CRP acted as an activator of type 3 fimbriae expression, contrasting with its repressive role under aerobic conditions. The biphasic regulatory activity of CRP was also observed in the promoter activity of cyclic diguanosine monophosphate (c-di-GMP)-related gene cluster mrkHIJ and the intracellular concentration of c-di-GMP. Among the nine c-di-GMP related genes containing a typical CRP binding site, the biphasic regulatory activity of CRP was also reflected in mediating the mRNA expression of D364_RS04770 (a putative diguanylate cyclase). Overexpression of D364_RS04770 not only increases type 3 fimbriae expression but also compensates for the absence of crp, further leading to the repression activity of CRP on type 3 fimbriae expression under anaerobic conditions. Furthermore, anaerobic conditions triggered the role of CRP in activating biofilm formation.
conclusionsOur study identifies a novel oxygen-dependent switch in CRP function and highlights D364_RS04770 as a key downstream effector, distinguishing this mechanism from previously known glucose-dependent regulation in K. pneumoniae CG43S3. Additionally, D364_RS04770 may act as a mediator to influence the regulation of CRP on type 3 fimbriae expression in response to oxygen availability. Understanding these regulatory mechanisms provides a deeper insight into bacterial pathogenesis and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.